Transforming growth factor-alpha and epidermal growth factor receptor in chronic liver disease and hepatocellular carcinoma

Citation
K. Harada et al., Transforming growth factor-alpha and epidermal growth factor receptor in chronic liver disease and hepatocellular carcinoma, LIVER, 19(4), 1999, pp. 318-325
Citations number
35
Categorie Soggetti
Gastroenerology and Hepatology","da verificare
Journal title
LIVER
ISSN journal
01069543 → ACNP
Volume
19
Issue
4
Year of publication
1999
Pages
318 - 325
Database
ISI
SICI code
0106-9543(199908)19:4<318:TGFAEG>2.0.ZU;2-S
Abstract
Aims/Background: Transforming growth factor-alpha (TGF-alpha) is a potent m itogen of normal and neoplastic hepatocytes. In addition, TGF-alpha has bee n reported to play a pivotal role in hepatocarcinogenesis. To evaluate the significance of TGF-alpha in chronic liver diseases and hepatocellular carc inoma, we examined serum TGF-alpha, and expression of TGF-alpha, epidermal growth factor receptor (EGFR) and proliferating ceh nuclear antigen (PCNA) mRNA in liver tissues. Methods: Thirty-five patients with chronic hepatitis (CH), 33 with liver cirrhosis (LC), 55 with hepatocellular carcinoma (HCC) and 53 normal controls (C) were enrolled in this study. Serum TGF-alpha le vels were measured by an enzyme-linked immunosorbent assay. Expression of T GF-alpha, EGFR, PCNA and beta-actin mRNA in liver tissues were examined by reverse transcription polymerase chain reaction. Results: Serum TGF-alpha l evels in C, CH, LC and HCC were 5.6 +/- 2.1, 33.2 +/- 8.3, 404.0 +/- 173.0 and 100.3 +/- 39.2 pg/ml, respectively Serum TGF-alpha level in LC was high er than in other diseases (p<0.01, compared to CH, HCC and C, respectively) . Serum TGF-alpha levels exhibited a significant positive correlation with total bilirubin, ICGR15 and Pugh score (p<0.01, p<0.01 and p<0.05, respecti vely), and increased in parallel with severity of disease according to Chil d classification. Although the ratios of TGF-alpha, EGFR and PCNA mRNA to b eta-actin mRNA were not significantly different among the diseases, the TGF -alpha/beta-actin ratio correlated with EGFR/beta-actin and PCNA/beta-actin ratios (p<0.001 and p<0.0001, respectively), and EGFR/beta-actin ratio was related to PCNA/beta-actin ratio in all patients, especially with HCC. Con clusion: The results of the present study suggest that serum TGF-alpha leve ls are closely related to severity of liver dysfunction, and that hepatic e xpression of TGF-alpha and EGFR correlates with proliferation of normal and neoplastic hepatocytes.